Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$7.83 USD
+0.01 (0.13%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $8.00 +0.17 (2.17%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
AMNEAL PHARMACEUTICALS, INC.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AMRX 7.83 +0.01(0.13%)
Will AMRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMRX
Amneal (AMRX) is an Incredible Growth Stock: 3 Reasons Why
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
AMRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
Indivior (INDV) Moves 5.7% Higher: Will This Strength Last?
Other News for AMRX
Amneal Pharmaceuticals announces unaudited preliminary Q2 revenue between $720M and $730M
Amneal Pharmaceuticals (AMRX) Reports Strong Growth and Strategic Advancements | AMRX Stock News
Amneal Pharmaceuticals (AMRX) Plans Major Financial Restructuring | AMRX Stock News
Amneal Pharmaceuticals Inc (AMRX) Announces New Financing Initiatives | AMRX stock news
Amneal Pharmaceuticals Inc (AMRX) Announces Preliminary Q2 2025 Financial Results | AMRX stock news